In a hemodialysis patient with bilateral pleural effusions, is placement of a tunneled indwelling pleural catheter (PleurX) appropriate?

PleurX Catheter in Hemodialysis Patients with Bilateral Pleural Effusions

Yes, a PleurX catheter can be placed in a hemodialysis patient with bilateral pleural effusions, but serial thoracocentesis should be offered as the first-line treatment option, with PleurX catheter reserved for refractory cases requiring ≥3 therapeutic thoracocenteses 1.

Treatment Algorithm for ESRF Patients with Pleural Effusions

Step 1: Establish Etiology and Rule Out Serious Causes

• Most common cause: Fluid overload in dialysis patients, but not all present with bilateral effusions or transudates 1
• Critical caveat: This population carries significant risk of pleural infection or malignancy 1
• If clinical suspicion exists, obtain cross-sectional imaging early in the diagnostic pathway 1

Step 2: Optimize Medical Management First

• Aggressive fluid removal during dialysis sessions
• High-dose diuretics
• Salt and fluid restriction
• For peritoneal dialysis patients: consider hypertonic exchanges, icodextrin fluid, or switch to hemodialysis 1

Step 3: Pleural Intervention Strategy When Medical Management Fails

First-line approach: Serial thoracocentesis 1

• Observational studies show similar symptomatic relief compared to IPCs
• Lower adverse event rates than IPCs
• Allows for repeated assessment and avoids permanent catheter complications

Second-line approach: PleurX catheter (IPC) 1, 2

• Reserved for refractory cases requiring ≥3 therapeutic thoracocenteses 1
• Consider when patient is hospitalized primarily for dyspnea from effusion and IPC would enable discharge 2

Third-line approach: Attempted talc pleurodesis 1

Safety and Efficacy Data for PleurX in ESRF

Evidence Supporting Use:

• Significant dyspnea improvement: Median transitional dyspnea index of 6 at 2 weeks post-insertion 2
• No empyema or major complications in case series of 8 ESRF patients 2
• Spontaneous pleurodesis achieved in 37.5% of patients after median 77 days 2
• No decrease in serum albumin after catheter insertion 2
• Pleural interventions shown to be relatively safe across observational studies in this population 1

Important Warnings:

• High adverse event rate and increased drainage volume with IPCs seen in RCTs of benign pleural effusions 1
• Tension hydrothorax risk: A 2026 case report documented sudden ventilatory failure and cardiopulmonary arrest immediately after bilateral PleurX placement in an 85-year-old ESRF patient on hemodialysis 3
• This population is frail with poor prognosis and high symptom burden; treatments are typically palliative intent 1

Key Clinical Considerations

Patient selection criteria for PleurX 2:

• Failed, complicated, or intolerant to maximal medical therapy
• Required thoracentesis twice within preceding 2 weeks
• No evidence of infection
• Hospitalized primarily for dyspnea from effusion where IPC enables discharge

Bilateral effusions: The 2026 case report highlights particular caution with bilateral PleurX placement due to risk of acute hemodynamic compromise in patients with limited preload reserve 3. Consider staged placement if bilateral catheters needed.

Proper caregiver training is essential for successful outcomes and infection prevention 4.